A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Clinical trial NCT00080054 · COMPLETED

Trial details

NCT number: NCT00080054
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Glioblastoma Astrocytoma Oligodendroglioma Brain Neoplasm

Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.